關於 Dendreon Corporation

Dendreon Pharmaceuticals LLC is a biotechnology company. Its lead product, Provenge, is an immunotherapy for prostate cancer. It consists of a mixture of the patient's own blood cells that have been incubated with the Dendreon PAP-GM-CSF fusion protein. Phase III clinical trial results demonstrating a survival benefit for prostate cancer patients receiving the drug were presented at the AUA meeting on April 28, 2009. After going through the approval process, Provenge was given full approval by the FDA on April 29, 2010. Dendreon's stock value fell 66% on August 4, 2011, after abandoning its forecast for its debut drug Provenge. Source: Wikipedia
總部Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
成立時間2013
狀態營運中

專利134 項專利

HUMORAL IMMUNE RESPONSE AGAINST TUMOR ANTIGENS AFTER TREATMENT WITH A CANCER ANTIGEN SPECIFIC ACTIVE IMMUNOTHERAPY AND ITS ASSOCIATION WITH…CA2923433C · 2020
Humoral immune response against tumor antigens after treatment with a cancer antigen specific active immunotherapy and its association with…US10261091B2 · 2019
登入即可查看全部 134 項專利

瀏覽完整的專利組合,包括公開號、日期及專利家族。

登入 使用電子郵件建立帳號

完全免費

在 Heelky 上搜尋所有專利 →

評價

尚無評論。與 Dendreon Corporation 合作過嗎?成為第一個分享經驗的人吧。

撰寫評論 →

聯絡方式與連結

地點

Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US

這是你的公司嗎?

免費認領此頁面,即可新增標誌、產品、照片與職缺,並回覆評論。

認領此頁面

分享這家公司

Dendreon CorporationCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, UShttps://heelky.com/explore/companies/dendreon-corporation-q9lqmwsf/

複製連結

分享到

QR Code

用手機相機掃描即可開啟此頁面,也可以下載用於傳單、簡報或名牌。

加入 Heelky,建立人脈、招募人才、持續成長

建立免費帳號,即可傳送訊息、應徵職缺並發布任務。

立即加入 — 完全免費

選擇語言

Heelky 會記住你的選擇。

其他語言

可用語言:70 關於 Heelky 的語言